First Trust Nasdaq Pharmaceuticals ETF
FTXHNASDAQFirst TrustEquity
As of Oct 23, 2026 close
- Assets (AUM)
- $1.08B
- Expense ratio
- 0.60%
- Dividend yield
- 0.67%
- Holdings
- 52
- 52-week range
- $29.25$43.52
- Volume (live)
- -
- Avg. volume (3M)
- 254.67K
FTXH ETF: First Trust Nasdaq Pharmaceuticals ETF - Price, Holdings & Analysis
First Trust Nasdaq Pharmaceuticals ETF Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
| Day's Range | $42.42 - $43.00 |
|---|---|
| 52-Week High | $43.52 |
| 52-Week Low | $29.25 |
| Open | $43.00 |
| Volume (last close) | 83.50K |
| Average Volume (3M) | 254.67K |
| 1 Day Change | +1.05% |
|---|---|
| 1 Month Change | +4.65% |
| 6 Month Change | +27.00% |
| YTD Change | +30.41% |
| 1 Year Change | +46.83% |
| 5 Year Change | +66.79% |
| 10 Year Change | +125.11% |
| Annual Dividend | $0.29 |
|---|---|
| Dividend Yield | 0.67% |
| Last Dividend Ex-Date | Sep 24, 2026 |
| Dividend Growth YoY | −37.51% |
| Assets (AUM) | $1.08B |
|---|---|
| Expense Ratio | 0.60% |
| Total Holdings | 52 |
| Inception Date | Sep 19, 2016 |
| 50-Day MA | $41.26 |
|---|---|
| 200-Day MA | $36.80 |
| RSI | 63.00 |
| Stochastic %K | 98.84 |
| Stochastic %D | 66.31 |
Source: Exchange price data and fund disclosures. Data as of Oct 23, 2026. Data sources and methodology
FTXH at a Glance
First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an equity ETF from First Trust, launched in September 2016. It manages $1.08B in assets and charges a 0.60% expense ratio, about $60 a year per $10,000 invested.
As of its Oct 4, 2026 holdings, it holds 52 positions. The largest are Merck & Co., Inc (MRK, 7.58%), Eli Lilly and Company (LLY, 7.43%) and AbbVie Inc. (ABBV, 7.37%). The top 10 holdings make up 58.1% of the fund. By sector it leans toward Healthcare (100.0%). 99.4% of assets are in the United States.
It pays distributions yielding 0.67% at the Oct 23, 2026 close, $0.29 per share over the trailing 12 months. As of the Oct 23, 2026 close, the share price is up 46.8% over one year, up 66.8% over five years and up 125.1% over ten years (price change, excluding distributions).
Frequently Asked Questions About First Trust Nasdaq Pharmaceuticals ETF
What is the current price of FTXH?
The latest FTXH price is $42.67 (Oct 23, 2026 close). The 52-week range is $29.25–$43.52. The share price is up 46.8% over the past year (price change, excluding distributions).
What is the expense ratio for FTXH?
FTXH's annual expense ratio is 0.60%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.
Does FTXH pay dividends?
Yes, FTXH pays a 0.67% dividend yield (trailing 12 months, at the Oct 23, 2026 close). The most recent ex-dividend date was September 24, 2026. View full dividend history in the Dividends section.
What are the top holdings of FTXH?
As of Oct 4, 2026, FTXH's largest holdings are Merck & Co., Inc (7.6%), Eli Lilly and Company (7.4%), AbbVie Inc. (7.4%) (combined weight: 22.4%). The fund holds 52 total positions. View the complete portfolio breakdown in the Holdings section.
How does FTXH compare to similar ETFs?
Compare FTXH (0.60% expense ratio, $1.08B AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.